Men's Health: The World Market for Current and Emerging Drug Therapies

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,625	228 Pages	Kalorama Information	August, 2003	KLI888599

Attention: There is an updated edition available for this report.

Best Price Guarantee
Price	from $2,625
Length	228 Pages
Publisher	Kalorama Information
Published Date	August, 2003
SKU	KLI888599

This Kalorama Information report—Men’s Health: The World Market for Current and Emerging Drug Therapies—focuses on treatment segments in which men are affected. These segments include:

· Men’s Cancer

· Sexual Function

· Sexually Transmitted Diseases

· Urinary Conditions

· Andropause

The report covers drugs that are used for the treatment of conditions affecting men, including prostate cancer, impotence, and BPH; and areas where diseases and men’s health are a major concern including HIV, herpes, and urinary incontinence. Revenues for product segments include the amount estimated for use in men, for example in the area of BPH 100 percent of revenues are attributed to use in men and between 20 and 30 percent of the total urinary incontinence is calculated for the men’s health market.

The report includes statistical information for conditions and diseases affecting the men worldwide, with special emphasis on the U.S. market. Each segment provides an overview, descriptions of products on the market, products in research and development, market estimates and forecasts, and competitive analysis of leading providers. In addition to above-mentioned information, the report includes current issues and trends affecting the industry and identifies trends that may arise in the future.

Executive Summary
- Scope And Methodology
- Size And Growth Of The Market
  - Table World Market For Men's Health Pharmaceuticals 2001-2008
- Issues And Trends Affecting Market
- Leading Competitors
Introduction
- History And Growth Of The Men's Health Industry
- Male Anatomy
- Male Reproductive Physiology
- Male Demographics And Statistics
  - Table World Male Population By Selected Geographical Region, 2002-2050
  - Table Life Expectancy At Birth By Selected Countries, 2000
  - Table United States Life Expectancy At Birth, 1990-2000, And Projections, 2005-2010
  - Table Estimated Male Prevalence Of Selected Risk Behavior By Geographical Region, 2002
Men's Cancer
- Description Of Cancers Affecting Men
  - Prostate Cancer
  - Testicular Cancer
  - Prevalence And Incidence
    - Table Men's Cancer: Estimated World Incidence And Prevalence (Thousands)
- Description Of Products
  - Hormone Therapies
  - Lhrh Analogs
  - Antiandrogens
  - Intermittent Hormone Therapy
  - Adjuvant Hormone Therapy
  - Chemotherapy Agents
  - Others
- Research And Development
  - Table Research And Development: Men's Cancer Therapies - Part 1
  - Table Research And Development: Men's Cancer Therapies - Part 2
- Market Size And Growth
  - World Market
    - Table World Market For Men's Cancer Therapies 2001-2008
    - Table World Marketfor Men's Cancer Therapies By Product Type 2001-2008
    - Table Compound Annual Growth Rate, 2002-2008
    - Table World Market For Men's Cancer Therapies Distribution Of Revenues By Type 2001-2008
  - U.S. Market
    - Table U.S. Market For Men's Cancer Therapies 2001-2008
  - Non-U.S. Market
    - Table Non-U.S. Market For Men's Cancer Therapies 2001-2008
- Competitive Analysis
  - Table World Market For Men's Cancer Therapies Leading Suppliers' Revenues And Market Shares 2002 And 2008
Men's Sexual Dysfunction
- Description Of Sexual Disorders Affecting Men
  - Erectile Dysfunction
  - Ejaculation Disorders
  - Prevalence And Incidence
    - Table Estimated World And U.S. Incidence And Prevalence For Men's Sexual Function
- Description Of Products
  - Phosphodiesterase Type V Inhibitors
  - Others
- Research And Development
  - Table Men's Sexual Dysfunction Therapies In Research And Development
- Market Size And Growth
  - World Market
    - Table World Market For Men's Sexual Dysfunction Therapies 2001-2008
    - Table World Market For Men's Sexual Dysfunction Therapies By Product Type 2001-2008
    - Table Compound Annual Growth Rate, 2002-2008
    - Table World Market For Men's Sexual Dysfunction Therapies Distribution Of Revenues By Product Type 2001-2008
  - U.S. Market
    - Table U.S. Market For Men's Sexual Dysfunction Therapies 2001-2008
  - Non-U.S. Market
    - Table Non-U.S. Market For Men's Sexual Function Therapies 2001-2008
- Competitive Analysis
  - Table World Market For Men's Sexual Dysfunction Therapies Leading Suppliers' Revenues And Market Shares 2002 And 2008
Sexually Transmitted Diseases
- Stds Affecting Men
  - Chlamydia
  - Genital Herpes
  - Genital Warts
  - Gonorrhea
  - Hiv/Aids
  - Syphilis
- Prevalence And Incidence
  - Table Men's Sexually Transmitted Diseases: Estimated World Incidence And Prevalence For Men (Thousands)
- Description Of Products
  - Antibiotics
  - Antiviral Therapies
  - Others
- Research And Development
  - Table Research And Development For Sexually Transmitted Disease Therapies - Part 1
  - Table Research And Development For Sexually Transmitted Disease Therapies - Part 2
  - Table Research And Development For Sexually Transmitted Disease Therapies - Part 3
- Market Size And Growth
  - World Market
    - Table World Market For Men's Sexually Transmitted Disease Therapies 2001-2008
    - Table World Market For Men's Sexually Transmitted Disease Therapies Revenues By Product Type 2001-2008
    - Table Compound Annual Growth Rate, 2002-2008
    - Table World Market For Men's Men's Sexually Transmitted Disease Therapies Distribution Of Revenues By Type 2001-2008
  - U.S. Market
    - Table U.S. Market For Men's Sexually Transmitted Disease Therapies 2001-2008
  - Non-U.S. Market
    - Table Non-U.S. Market For Men's Sexually Transmitted Disease Therapies, 2001-2008
- Competitive Analysis
  - Table World Market For Men's Sexually Transmitted Disease Therapies Leading Suppliers' Revenues And Market Shares 2002 And 2008
Men's Urinary Conditions
- Description Of Urinary Conditions Affecting Men
  - Benign Prostate Hypertrophy (Bph)
  - Prostatitis
  - Urinary Incontinence
- Prevalence And Incidence
  - Table Men's Urinary Conditions: Estimated World Incidence And Prevalence For Men (In Thousands)
- Description Of Products
  - Alpha Blockers
  - 5-Alpha Reductase Inhibitors
  - Anticholinergics
  - Antispasmodics
  - Others
- Research And Development
  - Table Research And Development: Urinary Condition Therapies - Part 1
  - Table Research And Development: Urinary Condition Therapies - Part 2
- Market Size And Growth
  - World Market
    - Table World Market For Men's Urinary Condition Therapies 2001-2008
    - Table World Market For Men's Urinary Condition Therapies By Product Type 2001-2008
    - Table Compound Annual Growth Rate
    - Table World Market For Men's Urinary Condition Therapies Distribution Of Revenues By Product Type 2001-2008
  - U.S. Market
    - Table U.S. Market For Men's Urinary Condition Therapies 2001-2008
  - Non-U.S. Market
    - Table Non-U.S. Market For Men's Urinary Condition Therapies 2001-2008
- Competitive Analysis
  - Table World Market For Men's Urinary Condition Therapies Leading Suppliers' Revenues And Market Shares 2002 And 2008
Male Menopause Or Andropause
- Description Of Male Menopause
  - Prevalence And Incidence
    - Table Andropause: Estimated World And U.S. Incidence And Prevalence (Thousands)
- Description Of Products
  - Androgens
- Research And Development
  - Table Research And Development: Andropause Therapies
- Market Size And Growth
  - World Market
    - Table World Market For Andropause Therapies 2001-2008
  - U.S. Market
    - Table U.S. Market For Andropause Therapies 2001-2008
  - Non-U.S. Market
    - Table Non-U.S. Market For Andropause Therapies 2001-2008
- Competitive Analysis
  - Table World Market For Andropause Therapies Leading Suppliers' Revenues And Market Shares 2002 And 2008
Issues And Trends
- Education And Awareness Of Men's Health
- Changing Life Expectancy
- Legislative Issues
- Early Detection And Screening
- Prodrug Treatment
- New Guidelines For Testosterone Replacement Therapy
- Pharmaceutical Growth Trends
- Marketing Budget Trends
- Direct-To-Consumer Advertising In Europe
World Market Summary
- Overview
- Total Market Size And Forecast
  - Table World Market: Men's Health, 2001-2008
- Markets By Segments
  - Table World Market For Men's Health Pharmaceuticals By Therapeutic Area 2001-2008
  - Table Compound Annual Growth Rate 2002-2008
  - Table World Market For Men's Health Pharmaceuticals Distribution Or Revenues By Therapeutic Area 2001-2008
- Competitor Analysis
  - Table Men's Health: Leading Suppliers Significant Segments Of Participation, 2002
- Market Analysis
Company Profiles
- Top Competitor Profiles
  - Abbott Laboratories
  - Alza Corporation
  - Astrazeneca Plc
  - Boehringer Ingelheim Gmbh
  - Bristol-Myers Squibb Company
  - Glaxosmithkline Plc
  - Merck & Company, Inc.
  - Pfizer, Inc.
  - Roche Group
  - Takeda Chemical Industries Ltd.
  - Tap Pharmaceutical Products Inc.
  - Unimed Pharmaceuticals, Inc. (Solvay)
  - Vivus, Inc.
  - Watson Pharmaceuticals, Inc.
  - Yamanouchi Pharmaceutical Company, Ltd.
- Emerging And R&D Company Profiles
  - Amgen, Inc.
  - Atrix Laboratories, Inc.
  - Auxilium Pharmaceuticals, Inc.
  - Bayer Corporation
  - Eli Lilly & Company
  - Gilead Sciences, Inc.
  - Hydro Med Sciences
  - Praecis Pharmaceuticals, Inc.
  - Timeris, Inc.
Regulatory Authorities And Professional And Academic Organizations
Company Directory